Innovative Valve Disease Therapies, a Potential Benefit for Patients but Calling for More Clinical Evaluation

Journal of Thoracic and Cardiovascular Surgery - United States
doi 10.1016/j.jtcvs.2018.07.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Interesting Results, but Potential for More Mechanistic Exploration

2019English

Neurodegenerative Disease: Two–for–one on Potential Therapies

Nature
Multidisciplinary
2017English

Prospects for Percutaneous Valve Therapies

Circulation
Cardiovascular MedicinePhysiologyCardiology
2007English

A Clinical Case of Repeat Tissue Valve Replacement for Recurrent Mitral Valve Disease

Complex Issues of Cardiovascular Diseases
2019English

Innovative Pricing Mechanisms for Therapies for Advanced Cancers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Php345 - Innovative Payment Models for Breakthrough Therapies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Potential Clinical Benefit of Tocilizumab Therapy for Patients With HHV-8-infected AIDS-related Multicentric Castleman Disease: A Case Report and Literature Review

Cureus
2020English

Innovative Methods for Biomarker Discovery in the Evaluation and Development of Cancer Precision Therapies

Cancer and Metastasis Reviews
Cancer ResearchOncology
2018English

Innovation Potential as a Subsystem of Potential for Innovative Development

PROBLEMS OF SYSTEMIC APPROACH IN THE ECONOMY
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy